Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 6, 2009
Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesisF Cianchi, S Cuzzocrea, M C Vinci, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Transcripts with splicings of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancerR Palmirotta, M C Verì, M C Curia, et al.
British Journal of Cancer|January 26, 2000
APC gene mutations and colorectal adenomatosis in familial adenomatous polyposisF Ficari, A Cama, R Valanzano, et al.
La Radiologia Medica|January 30, 2013
Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experienceD Greto, F Paiar, C Saieva, et al.
Cancer Research|August 14, 1999
Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancerM C Curia, R Palmirotta, G Aceto, et al.
Minerva Endocrinologica|December 26, 2001
[Somatostatin receptors in non-endocrine tumours]C Casini Raggi, P Pinzani, S Gelmini, et al.
La Clinica Terapeutica|August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]M Lopez, A Comandone, V Adamo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 3, 2014
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohortE Lastraioli, L Boni, M R Romoli, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Pageof 4